Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 174

1.

[Measurement of out-of-field dose to the uterus during proton therapy of the head and neck].

le Guevelou J, Trompier F, Villagrasa C, Vela A, Isambert A, Herault J, Thariat J.

Cancer Radiother. 2020 Feb 12. pii: S1278-3218(20)30014-7. doi: 10.1016/j.canrad.2019.10.004. [Epub ahead of print] French.

PMID:
32061532
2.

Oncologic and visual outcomes after postoperative proton therapy of localized conjunctival melanomas.

Thariat J, Salleron J, Maschi C, Fevrier E, Lassalle S, Gastaud L, Baillif S, Claren A, Baumard F, Herault J, Caujolle JP.

Radiat Oncol. 2019 Dec 27;14(1):239. doi: 10.1186/s13014-019-1426-6.

3.

Ultra-widefield fundus photography for radiation therapy planning of ocular tumours.

Mathis T, Espensen CA, Caujolle JP, Herault J, Fog LS, Maschi C, Kodjikian L, Baillif S, Kiilgaard JF, Thariat J.

Acta Ophthalmol. 2020 Mar;98(2):e191-e196. doi: 10.1111/aos.14250. Epub 2019 Sep 13.

PMID:
31518055
4.

Experimental characterisation of a proton kernel model for pencil beam scanning techniques.

De Marzi L, Da Fonseca A, Moignier C, Patriarca A, Goudjil F, Mazal A, Buvat I, Hérault J.

Phys Med. 2019 Aug;64:195-203. doi: 10.1016/j.ejmp.2019.07.013. Epub 2019 Jul 23.

PMID:
31515020
5.

RGD-functionalized magnetosomes are efficient tumor radioenhancers for X-rays and protons.

Hafsi M, Preveral S, Hoog C, Hérault J, Perrier GA, Lefèvre CT, Michel H, Pignol D, Doyen J, Pourcher T, Humbert O, Thariat J, Cambien B.

Nanomedicine. 2020 Jan;23:102084. doi: 10.1016/j.nano.2019.102084. Epub 2019 Aug 24.

PMID:
31454552
6.

[Proton therapy for head and neck squamous cell carcinomas: From physics to clinic].

Beddok A, Vela A, Calugaru V, Tessonnier T, Kubes J, Dutheil P, Gérard A, Vidal M, Goudjil F, Florescu C, Kammerer E, Bénézery K, Hérault J, Bourhis J, Thariat J; Gortec et de trois centres français.

Cancer Radiother. 2019 Sep;23(5):439-448. doi: 10.1016/j.canrad.2019.05.015. Epub 2019 Jul 26. Review. French.

PMID:
31358445
7.

Activation of Collimators Irradiated With Clinical Proton Beams and Development of a Semiempirical Model for Activity Calculation.

Carnicer A, Candela-Juan C, Nirrengarten M, Blideanu V, Mazal A, Hérault J, Delacroix S.

Health Phys. 2019 Nov;117(5):509-525. doi: 10.1097/HP.0000000000001082.

PMID:
31211755
8.

Proton radiotherapy in advanced malignant melanoma of the conjunctiva.

Scholz SL, Hérault J, Stang A, Griewank KG, Meller D, Thariat J, Steuhl KP, Westekemper H, Sauerwein W.

Graefes Arch Clin Exp Ophthalmol. 2019 Jun;257(6):1309-1318. doi: 10.1007/s00417-019-04286-2. Epub 2019 Mar 27.

PMID:
30919076
9.

The Lens Opacities Classification System III Grading in Irradiated Uveal Melanomas to Characterize Proton Therapy-Induced Cataracts.

Mathis T, Rosier L, Meniai F, Baillif S, Maschi C, Herault J, Caujolle JP, Kodjikian L, Salleron J, Thariat J.

Am J Ophthalmol. 2019 May;201:63-71. doi: 10.1016/j.ajo.2019.01.025. Epub 2019 Feb 2.

PMID:
30721686
10.

Study of the responses and calibration procedures of neutron and gamma area and environmental detectors for use in proton therapy.

Carnicer A, Angellier G, Hofverberg P, Bergerot JM, Gerard A, Peucelle C, Vidal M, Hérault J.

J Radiol Prot. 2019 Mar;39(1):250-278. doi: 10.1088/1361-6498/aaf437. Epub 2019 Feb 5.

PMID:
30721148
11.

Management of Invasive Squamous Cell Carcinomas of the Conjunctiva.

Santoni A, Thariat J, Maschi C, Herault J, Baillif S, Lassalle S, Peyrichon ML, Salleron J, Caujolle JP.

Am J Ophthalmol. 2019 Apr;200:1-9. doi: 10.1016/j.ajo.2018.11.024. Epub 2018 Dec 12.

PMID:
30552889
12.

Influence of Linear Energy Transfer on the Nucleo-shuttling of the ATM Protein: A Novel Biological Interpretation Relevant for Particles and Radiation.

Maalouf M, Granzotto A, Devic C, Bodgi L, Ferlazzo M, Peaucelle C, Bajard M, Giraud JY, Balosso J, Hérault J, Biston MC, Malet C, Foray N.

Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):709-718. doi: 10.1016/j.ijrobp.2018.10.011. Epub 2018 Oct 19.

PMID:
30342967
13.

20-year assessment of metastatic latency and subsequent time to death after proton therapy for uveal melanomas.

Bellocq D, Roy P, Kodjikian L, Mathis T, Nguyen AM, Herault J, Rivoire M, Négrier S, Thariat J, Grange JD.

Melanoma Res. 2018 Oct 12. doi: 10.1097/CMR.0000000000000519. [Epub ahead of print]

PMID:
30320630
14.

[Management of uveal melanomas, guidelines for oncologists].

Mathis T, Cassoux N, Tardy M, Piperno S, Gastaud L, Dendale R, Maschi C, Nguyen AM, Meyer L, Bonnin N, Baillif S, Tick S, Mouriaux F, Jaspart F, Dellis J, Rosier L, Desjardins L, Herault J, Caujolle JP, Thariat J.

Bull Cancer. 2018 Oct;105(10):967-980. doi: 10.1016/j.bulcan.2018.07.011. Epub 2018 Sep 11. Review. French.

PMID:
30217336
15.

Occurrence of Phosphenes in Patients Undergoing Proton Beam Therapy for Ocular Tumor.

Mathis T, Hofverberg P, Caujolle JP, Hérault J, Leal C, Maschi C, Delaunay B, Baillif S, Kodjikian L, Thariat J.

Am J Ophthalmol. 2018 Aug;192:31-38. doi: 10.1016/j.ajo.2018.05.006. Epub 2018 May 26.

PMID:
29753854
16.

Proton Beam Therapy for Iris Melanomas in 107 Patients.

Thariat J, Rahmi A, Salleron J, Mosci C, Butet B, Maschi C, Lanza F, Lanteri S, Baillif S, Herault J, Mathis T, Caujolle JP.

Ophthalmology. 2018 Apr;125(4):606-614. doi: 10.1016/j.ophtha.2017.10.009. Epub 2017 Nov 8.

PMID:
29128229
17.

Cataract Avoidance With Proton Therapy in Ocular Melanomas.

Thariat J, Jacob S, Caujolle JP, Maschi C, Baillif S, Angellier G, Mathis T, Rosier L, Carnicer A, Hérault J, Salleron J.

Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5378-5386. doi: 10.1167/iovs.17-22557.

PMID:
29049739
18.

Mechanisms of phosphenes in irradiated patients.

Mathis T, Vignot S, Leal C, Caujolle JP, Maschi C, Mauget-Faÿsse M, Kodjikian L, Baillif S, Herault J, Thariat J.

Oncotarget. 2017 Jun 28;8(38):64579-64590. doi: 10.18632/oncotarget.18719. eCollection 2017 Sep 8. Review.

19.

Lipase-catalyzed Synthesis of Oleoyl-lysophosphatidylcholine by Direct Esterification in Solvent-free Medium without Water Removal.

Mnasri T, Ergan F, Herault J, Pencreac'h G.

J Oleo Sci. 2017 Sep 1;66(9):1009-1016. doi: 10.5650/jos.ess17046. Epub 2017 Aug 8.

20.

Submillimeter ionoacoustic range determination for protons in water at a clinical synchrocyclotron.

Lehrack S, Assmann W, Bertrand D, Henrotin S, Herault J, Heymans V, Stappen FV, Thirolf PG, Vidal M, Van de Walle J, Parodi K.

Phys Med Biol. 2017 Aug 18;62(17):L20-L30. doi: 10.1088/1361-6560/aa81f8.

PMID:
28742053
21.

Effects of proton versus photon irradiation on (lymph)angiogenic, inflammatory, proliferative and anti-tumor immune responses in head and neck squamous cell carcinoma.

Lupu-Plesu M, Claren A, Martial S, N'Diaye PD, Lebrigand K, Pons N, Ambrosetti D, Peyrottes I, Feuillade J, Hérault J, Dufies M, Doyen J, Pagès G.

Oncogenesis. 2017 Jul 3;6(7):e354. doi: 10.1038/oncsis.2017.56.

22.

Dry Eye Syndrome After Proton Therapy of Ocular Melanomas.

Thariat J, Maschi C, Lanteri S, Peyrichon ML, Baillif S, Herault J, Salleron J, Caujolle JP.

Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):142-151. doi: 10.1016/j.ijrobp.2017.01.199. Epub 2017 Jan 29.

PMID:
28586953
23.

Conservative Treatments of Ocular Melanomas: Technology Used Wisely.

Thariat J, Herault J, Mouriaux F.

Int J Radiat Oncol Biol Phys. 2017 Jul 1;98(3):501-503. doi: 10.1016/j.ijrobp.2017.02.212. Epub 2017 Apr 25. No abstract available.

PMID:
28454734
24.

[Indications and results for protontherapy in cancer treatments].

Doyen J, Bondiau PY, Benezery K, Thariat J, Vidal M, Gérard A, Hérault J, Carrie C, Hannoun-Lévi JM.

Cancer Radiother. 2016 Oct;20(6-7):513-8. doi: 10.1016/j.canrad.2016.06.005. Epub 2016 Sep 7. Review. French.

PMID:
27614508
25.

Molecular Mechanism of SSR128129E, an Extracellularly Acting, Small-Molecule, Allosteric Inhibitor of FGF Receptor Signaling.

Herbert C, Schieborr U, Saxena K, Juraszek J, De Smet F, Alcouffe C, Bianciotto M, Saladino G, Sibrac D, Kudlinzki D, Sreeramulu S, Brown A, Rigon P, Herault JP, Lassalle G, Blundell TL, Rousseau F, Gils A, Schymkowitz J, Tompa P, Herbert JM, Carmeliet P, Gervasio FL, Schwalbe H, Bono F.

Cancer Cell. 2016 Jul 11;30(1):176-178. doi: 10.1016/j.ccell.2016.06.015. Epub 2016 Jul 11. No abstract available.

26.

Phosphenes in patients receiving radiotherapy.

Thariat J, Leal C, d'Ascoli A, Jardel P, Caujolle JP, Herault J, Baillif S, Maschi C, Loreti G.

Lancet Oncol. 2016 Jul;17(7):869-871. doi: 10.1016/S1470-2045(16)30034-1. No abstract available.

PMID:
27396635
27.

Practice Patterns Analysis of Ocular Proton Therapy Centers: The International OPTIC Survey.

Hrbacek J, Mishra KK, Kacperek A, Dendale R, Nauraye C, Auger M, Herault J, Daftari IK, Trofimov AV, Shih HA, Chen YE, Denker A, Heufelder J, Horwacik T, Swakoń J, Hoehr C, Duzenli C, Pica A, Goudjil F, Mazal A, Thariat J, Weber DC.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):336-343. doi: 10.1016/j.ijrobp.2016.01.040. Epub 2016 Jan 28.

PMID:
27084651
28.

Visual Outcomes of Parapapillary Uveal Melanomas Following Proton Beam Therapy.

Thariat J, Grange JD, Mosci C, Rosier L, Maschi C, Lanza F, Nguyen AM, Jaspart F, Bacin F, Bonnin N, Gaucher D, Sauerwein W, Angellier G, Hérault J, Caujolle JP.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):328-335. doi: 10.1016/j.ijrobp.2015.12.011. Epub 2015 Dec 23.

PMID:
27084650
29.

Influence of beam incidence and irradiation parameters on stray neutron doses to healthy organs of pediatric patients treated for an intracranial tumor with passive scattering proton therapy.

Bonfrate A, Farah J, De Marzi L, Delacroix S, Hérault J, Sayah R, Lee C, Bolch WE, Clairand I.

Phys Med. 2016 Apr;32(4):590-9. doi: 10.1016/j.ejmp.2016.03.009. Epub 2016 Apr 2.

PMID:
27050170
30.

Outcomes After Proton Beam Therapy for Large Choroidal Melanomas in 492 Patients.

Bensoussan E, Thariat J, Maschi C, Delas J, Schouver ED, Hérault J, Baillif S, Caujolle JP.

Am J Ophthalmol. 2016 May;165:78-87. doi: 10.1016/j.ajo.2016.02.027. Epub 2016 Mar 3.

PMID:
26940166
31.

Proton beams in cancer treatments: Clinical outcomes and dosimetric comparisons with photon therapy.

Doyen J, Falk AT, Floquet V, Hérault J, Hannoun-Lévi JM.

Cancer Treat Rev. 2016 Feb;43:104-12. doi: 10.1016/j.ctrv.2015.12.007. Epub 2016 Jan 5. Review.

PMID:
26827698
32.

Investigation of the selectivity of thrombin-binding aptamers for thrombin titration in murine plasma.

Trapaidze A, Hérault JP, Herbert JM, Bancaud A, Gué AM.

Biosens Bioelectron. 2016 Apr 15;78:58-66. doi: 10.1016/j.bios.2015.11.017. Epub 2015 Nov 10.

PMID:
26594887
33.

[Operative therapy and irradiation of conjunctival melanoma].

Westekemper H, Meller D, Darawsha R, Scholz SL, Flühs D, Steuhl KP, Hérault J, Thariat J, Sauerwein W.

Ophthalmologe. 2015 Nov;112(11):899-900, 902-6. doi: 10.1007/s00347-015-0147-y. Review. German.

PMID:
26475337
34.

Tumour Response in Uveal Melanomas Treated with Proton Beam Therapy.

Maschi C, Thariat J, Herault J, Caujolle JP.

Clin Oncol (R Coll Radiol). 2016 Mar;28(3):198-203. doi: 10.1016/j.clon.2015.08.007. Epub 2015 Sep 15.

PMID:
26385821
35.

Dynamics of reversals and condensates in two-dimensional Kolmogorov flows.

Mishra PK, Herault J, Fauve S, Verma MK.

Phys Rev E Stat Nonlin Soft Matter Phys. 2015 May;91(5):053005. Epub 2015 May 11.

PMID:
26066247
36.

Diatom milking: a review and new approaches.

Vinayak V, Manoylov KM, Gateau H, Blanckaert V, Hérault J, Pencréac'h G, Marchand J, Gordon R, Schoefs B.

Mar Drugs. 2015 Apr 29;13(5):2629-65. doi: 10.3390/md13052629. Review. Erratum in: Mar Drugs. 2015 Dec;13(12):7301.

37.

[Proton imaging applications for proton therapy: state of the art].

Amblard R, Floquet V, Angellier G, Hannoun-Lévi JM, Hérault J.

Cancer Radiother. 2015 Apr;19(2):139-51; quiz 152-6. doi: 10.1016/j.canrad.2014.04.011. Epub 2015 Jan 29. Review. French.

PMID:
25640216
38.

[Nanoparticles and radiation therapy].

Calugaru V, Magné N, Hérault J, Bonvalot S, Le Tourneau C, Thariat J.

Bull Cancer. 2015 Jan;102(1):83-91. doi: 10.1016/j.bulcan.2014.10.002. Epub 2015 Jan 9. Review. French.

PMID:
25609487
39.

Management of choroidal metastases.

Jardel P, Sauerwein W, Olivier T, Bensoussan E, Maschi C, Lanza F, Mosci C, Gastaud L, Angellier G, Marcy PY, Herault J, Caujolle JP, Dendale R, Thariat J.

Cancer Treat Rev. 2014 Dec;40(10):1119-28. doi: 10.1016/j.ctrv.2014.09.006. Epub 2014 Oct 5. Review.

PMID:
25451606
40.

Targeted identification of sialoglycoproteins in hypoxic endothelial cells and validation in zebrafish reveal roles for proteins in angiogenesis.

Delcourt N, Quevedo C, Nonne C, Fons P, O'Brien D, Loyaux D, Diez M, Autelitano F, Guillemot JC, Ferrara P, Muriana A, Callol C, Hérault JP, Herbert JM, Favre G, Bono F.

J Biol Chem. 2015 Feb 6;290(6):3405-17. doi: 10.1074/jbc.M114.618611. Epub 2014 Nov 10.

41.

Optimum reduction of the dynamo threshold by a ferromagnetic layer located in the flow.

Herault J, Pétrélis F.

Phys Rev E Stat Nonlin Soft Matter Phys. 2014 Sep;90(3):033015. Epub 2014 Sep 29.

PMID:
25314537
42.

Optimization of protein electroextraction from microalgae by a flow process.

Coustets M, Joubert-Durigneux V, Hérault J, Schoefs B, Blanckaert V, Garnier JP, Teissié J.

Bioelectrochemistry. 2015 Jun;103:74-81. doi: 10.1016/j.bioelechem.2014.08.022. Epub 2014 Aug 29.

PMID:
25216607
43.

N-[6-(4-butanoyl-5-methyl-1H-pyrazol-1-yl)pyridazin-3-yl]-5-chloro-1-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-1H-indole-3-carboxamide (SAR216471), a novel intravenous and oral, reversible, and directly acting P2Y12 antagonist.

Boldron C, Besse A, Bordes MF, Tissandié S, Yvon X, Gau B, Badorc A, Rousseaux T, Barré G, Meneyrol J, Zech G, Nazare M, Fossey V, Pflieger AM, Bonnet-Lignon S, Millet L, Briot C, Dol F, Hérault JP, Savi P, Lassalle G, Delesque N, Herbert JM, Bono F.

J Med Chem. 2014 Sep 11;57(17):7293-316. doi: 10.1021/jm500588w. Epub 2014 Aug 25.

PMID:
25075638
44.

Proton beam therapy for presumed and confirmed iris melanomas: a review of 36 cases.

Rahmi A, Mammar H, Thariat J, Angellier G, Herault J, Chauvel P, Kodjikian L, Denis P, Grange JD.

Graefes Arch Clin Exp Ophthalmol. 2014 Sep;252(9):1515-21. doi: 10.1007/s00417-014-2735-y. Epub 2014 Jul 20.

PMID:
25038910
45.

Dynamo efficiency controlled by hydrodynamic bistability.

Miralles S, Herault J, Fauve S, Gissinger C, Pétrélis F, Daviaud F, Dubrulle B, Boisson J, Bourgoin M, Verhille G, Odier P, Pinton JF, Plihon N.

Phys Rev E Stat Nonlin Soft Matter Phys. 2014 Jun;89(6):063023. Epub 2014 Jun 30. Erratum in: Phys Rev E Stat Nonlin Soft Matter Phys. 2014 Jul;90(1):019901. Herault, Johann [corrected to Herault, Johann].

PMID:
25019895
46.

Decay rates of magnetic modes below the threshold of a turbulent dynamo.

Herault J, Pétrélis F, Fauve S.

Phys Rev E Stat Nonlin Soft Matter Phys. 2014 Apr;89(4):043004. Epub 2014 Apr 4.

PMID:
24827329
47.

Monte Carlo modeling of proton therapy installations: a global experimental method to validate secondary neutron dose calculations.

Farah J, Martinetti F, Sayah R, Lacoste V, Donadille L, Trompier F, Nauraye C, De Marzi L, Vabre I, Delacroix S, Hérault J, Clairand I.

Phys Med Biol. 2014 Jun 7;59(11):2747-65. doi: 10.1088/0031-9155/59/11/2747. Epub 2014 May 6.

PMID:
24800943
48.

Tumor vasculature is regulated by FGF/FGFR signaling-mediated angiogenesis and bone marrow-derived cell recruitment: this mechanism is inhibited by SSR128129E, the first allosteric antagonist of FGFRs.

Fons P, Gueguen-Dorbes G, Herault JP, Geronimi F, Tuyaret J, Frédérique D, Schaeffer P, Volle-Challier C, Herbert JM, Bono F.

J Cell Physiol. 2015 Jan;230(1):43-51. doi: 10.1002/jcp.24656.

PMID:
24760775
49.

Secondary neutron doses received by paediatric patients during intracranial proton therapy treatments.

Sayah R, Farah J, Donadille L, Hérault J, Delacroix S, De Marzi L, De Oliveira A, Vabre I, Stichelbaut F, Lee C, Bolch WE, Clairand I.

J Radiol Prot. 2014 Jun;34(2):279-96. doi: 10.1088/0952-4746/34/2/279. Epub 2014 Apr 4.

PMID:
24704989
50.

Specific Inhibition of the VEGFR-3 Tyrosine Kinase by SAR131675 Reduces Peripheral and Tumor Associated Immunosuppressive Myeloid Cells.

Espagnolle N, Barron P, Mandron M, Blanc I, Bonnin J, Agnel M, Kerbelec E, Herault JP, Savi P, Bono F, Alam A.

Cancers (Basel). 2014 Feb 28;6(1):472-90. doi: 10.3390/cancers6010472.

Supplemental Content

Loading ...
Support Center